S. Dhooria, “A real-world study of the tolerability and dosing of pirfenidone and its effect on survival in idiopathic pulmonary fibrosis: Pirfenidone dose and survival in IPF”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 37, no. 2, pp. 148–157, Jun. 2020, doi: 10.36141/svdld.v37i2.8718.